Tag
#Drug Safety
Explore articles tagged with Drug Safety
Industry News
Cheaper Obesity Drugs: Cure or Crisis for India?
HRV Pharma's CEO examines the implications of cheaper GLP-1 obesity drugs coming to India post-semaglutide patent expiry, highlighting both transformative potential and misuse risks requiring careful regulation.